Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide in Parkinson's Disease
NCT04232969Phase 3Completed
- Sponsor
- University College London
- Start
- Jan 2020
- Primary completion
- Feb 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of exenatide in Parkinson's disease (PD), sponsored by University College London. Started Jan 2020; status: completed.
02
Drugs
exenatide
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT04232969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04232969.